Clinical Trial: Panuri Performance Study

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587866) titled 'Panuri Performance Study' on May 05.

Brief Summary: The main purpose of the study is to assess the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma (PDAC) the most common type of pancreatic cancer that accounts for approximately 90% of all pancreatic cancer cases.

The study aims to characterize the performance of the Panuri test in detecting pancreatic ductal adenocarcinoma in patients with symptoms supporting a clinical suspicion of pancreatic cancer The Panuri test is intended for professional laboratory use for diagnostic purposes.

Study Start Date: May, 2026

Study Type: OBSERVATIONAL

Condition: Pa...